| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SCICLONE PHARMACEUTICALS INC COM | 2,048,638 | 22,535,000 | 26.58% | ||
| 2 | VANDA PHARMACEUTICALS INC COM | 2,068,297 | 17,291,000 | 20.39% | ||
| 3 | VERICEL CORP | 1,417,939 | 8,309,000 | 9.80% | ||
| 4 | PAIN THERAPEUTICS INC | 3,530,401 | 7,873,000 | 9.28% | ||
| 5 | TOBIRA THERAPEUTICS INC | 832,977 | 6,814,000 | 8.04% | ||
| 6 | CUTERA INC COM | 372,300 | 4,188,000 | 4.94% | ||
| 7 | SAGENT PHARMACEUTICALS INC | 333,065 | 4,053,000 | 4.78% | ||
| 8 | PERNIX THERAPEUTICS HLDGS IN | 3,215,861 | 3,377,000 | 3.98% | ||
| 9 | PERNIX THERAPEUTICS HLDGS IN | 6,000,000 | 2,318,000 | 2.73% | PRN | |
| 10 | CTI BIOPHARMA CORP | 3,743,340 | 1,989,000 | 2.35% | ||
| 11 | ZELTIQ AESTHETICS INCORPORATED | 70,000 | 1,901,000 | 2.24% | ||
| 12 | DERMA SCIENCES INC COM PAR .01 | 507,799 | 1,574,000 | 1.86% | ||
| 13 | SOCIETAL CDMO INC | 236,874 | 1,414,000 | 1.67% | ||
| 14 | BIOSPECIFICS TECHNOLOGIES CORP COM | 25,637 | 893,000 | 1.05% | ||
| 15 | RAPTOR PHARMACEUTICAL CORP | 20,000 | 92,000 | 0.11% | ||
| 16 | SUCAMPO PHARMACEUTICALS INC | 5,228 | 57,000 | 0.07% | ||
| 17 | ANI PHARMACEUTICALS INC COM | 1,650 | 56,000 | 0.07% | ||
| 18 | INSYS THERAPEUTICS INC NEW COM NEW | 2,000 | 32,000 | 0.04% | ||
| 19 | BioDelivery Sciences International Inc | 8,523 | 28,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-064477, filed 2016.05.11).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
